Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol

BACKGROUND: Certolizumab pegol is used to treat ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, and rheumatoid arthritis. Unlike other monoclonal antibodies such as infliximab and adalimumab, certolizumab does not contain an Fc fraction and hence does not induce complement activation....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Balkan Med J
Main Authors: Baysal, Mehmet, Ümit, Elif Gülsüm, Sarıtaş, Fatih, Kodal, Nil Su, Demir, Ahmet Muzaffer
Format: Artigo
Sprog:Inglês
Udgivet: Galenos Publishing 2018
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6158467/
https://ncbi.nlm.nih.gov/pubmed/29687787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/balkanmedj.2017.1224
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker